Dexmedetomidin Labatec 200 μg/2 ml

Dexmedetomidin Labatec 200 μg/2 ml is a medicine authorised by Swissmedic under authorisation number 69348. The authorisation holder is Labatec Pharma SA. The medicinal product code is Synthetic medicines and the dispensing category is A: Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly. First authorisation was granted on 11 January 2024 and the authorisation is limited until 10 January 2029. ATC code N05CM18 places the medicine in the group Psycholeptics.

  • Dispensing category A
  • Authorisation number 69348
  • ATC N05CM18
  • Synthetic medicines
Authorisation data
Authorisation number69348
NameDexmedetomidin Labatec 200 μg/2 ml
Full nameDexmedetomidin Labatec 200 μg/2 ml, solution à diluer pour perfusion
Authorisation holderLabatec Pharma SA
Medicinal product codeSynthetic medicines
Dispensing categoryA · Prescription, not repeatable
ATC codeN05CM18
First authorisation11 January 2024
Authorisation validity10 January 2029
Strengths
No.NameDispensing categoryAuthorisation date
1Dexmedetomidin Labatec 200 μg/2 ml, solution à diluer pour perfusionA11 January 2024
2Dexmedetomidin Labatec 400 μg/4 ml, solution à diluer pour perfusionA11 January 2024
3Dexmedetomidin Labatec 1000 μg/10 ml, solution à diluer pour perfusionA11 January 2024

Scroll the table sideways

Pack sizes
Pack codeQuantityUnitATCIT codeDispensing category
15Ampulle(n)N05CM1801.04.1.A
25Ampulle(n)N05CM1801.04.1.A
35Ampulle(n)N05CM1801.04.1.A

Scroll the table sideways

Medicines in the same ATC group

Other medicines from this authorisation holder

Frequently asked questions

Is Dexmedetomidin Labatec 200 μg/2 ml authorised in Switzerland?

Yes. Dexmedetomidin Labatec 200 μg/2 ml is authorised by Swissmedic under authorisation number 69348, data as of 01 September 2026. The authorisation is limited until 10 January 2029.

Which dispensing category does Dexmedetomidin Labatec 200 μg/2 ml have?

Dexmedetomidin Labatec 200 μg/2 ml is in dispensing category A. Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly.

Who is the authorisation holder of Dexmedetomidin Labatec 200 μg/2 ml?

The authorisation holder is Labatec Pharma SA. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.

Sources

Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.

Authorisation in Switzerland?

About 2 minutes. No obligation.

First, a little about your business.

Your answers stay in this page until you send your enquiry.

What would you like to achieve?

Your project

Where can we reach you?

You can go back to review your answers before sending.

* Required fields
Prefer email? info@swissmedicinesdirectory.com